Obesity to fuel rise in liver cancer cases
Researchers said that the proportion of liver cancers caused by the most common cause of liver cancer – the hepatitis B virus – are set to reduce over the coming years.
Cases caused by the hepatitis C virus are also expected to decline proportionately.
But in contrast, liver cancer cases caused by alcohol and obesity are set to increase.
Experts predicted that by 2050 some 21% of liver cancers will be caused by alcohol.
And 11% will be caused by a severe form of metabolic dysfunction-associated steatotic liver disease (MASLD) – formerly known as fatty liver disease, where fat builds up in a person's liver.
The severe form of this condition is called metabolic dysfunction-associated steatohepatitis.
The research team point out that 60% of liver cancers are preventable.
They said that global deaths from liver cancer are expected to rise from 760,000 in 2022 to 1.37 million in 2050.
'These data suggest that preventive measures targeting a comprehensive number of risk factors for hepatocellular carcinoma are sorely needed,' the team of experts led by academics in Hong Kong wrote.
The main treatment for MASLD is eating a balanced diet, being physically active and potentially losing weight.
'Liver cancer is a growing health issue around the world,' said Professor Jian Zhou, chairman of the Commission from Fudan University in China.
#BetterHealth offers a range of free NHS apps to help people eat better and get active, including the NHS Weight Loss Plan app.
Data shows it can help people lose 5.8kg on average over just 12 weeks. Find out more: https://t.co/Bv6bumO9ZU pic.twitter.com/XQuL0z6unA
— NHS London (@NHSEnglandLDN) July 25, 2023
'It is one of the most challenging cancers to treat, with five-year survival rates ranging from approximately 5% to 30%.
'We risk seeing close to a doubling of cases and deaths from liver cancer over the next quarter of a century without urgent action to reverse this trend.'
First author, Professor Stephen Chan, from the Chinese University of Hong Kong, added: 'As three in five cases of liver cancer are linked to preventable risk factors, mostly viral hepatitis, alcohol and obesity, there is a huge opportunity for countries to target these risk factors, prevent cases of liver cancer and save lives.'
Commenting on the study, Pamela Healy, chief executive of the British Liver Trust, said: 'Liver cancer is the fastest rising cause of cancer death in the UK, and just 13% of people diagnosed will survive for five years or more.
'We know that the biggest risk factors are having pre-existing liver cirrhosis or viral hepatitis, and this new analysis highlights that MASLD, also known as fatty liver disease, is expected to be linked to an increasing number of cases.
'As well as improving early detection through surveillance of people with cirrhosis, it is essential that we tackle these underlying causes and prioritise public health.
'By supporting people to maintain a healthy weight, cut down on alcohol and get tested and treated for hepatitis, we can prevent many cases of liver cancer and save lives.'
In 2022, some 64% of adults in England were estimated to be overweight or living with obesity.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mirror
4 days ago
- Daily Mirror
Brits urged by NHS to test themselves for 'life-threatening' infection
Brits have been urged to test themselves for an infection that can be 'life-threatening'. The NHS took to its Instagram page to share the health recommendation to its followers The NHS is calling on Brits who are worried they may be at risk of Hepatitis C to test themselves. According to the NHS website, Hepatitis C is a virus that targets the liver. Without treatment, it can occasionally result in severe and potentially fatal liver damage over extended periods. However, contemporary Hepatitis C treatments typically enable a complete cure of the infection, with most sufferers enjoying a standard life expectancy. Estimates suggest approximately 118,000 individuals in the UK were living with chronic hepatitis C in 2019. Infection occurs through contact with the blood of someone who carries the virus. "Lots of people have hepatitis C without knowing it. If untreated, it can damage your liver and can sometimes lead to life-threatening conditions," the NHS stated in an Instagram post on its official page. The post went on to say: "If you're worried you may be at risk of hepatitis C, you can order a free and confidential test online. "Search 'hep C test NHS' to find out more information and order a test". What are the symptoms of Hepatitis C? Hepatitis C frequently presents no obvious symptoms until significant liver damage has occurred. This means numerous individuals carry the infection unknowingly. When symptoms do manifest, they may be confused with other conditions. Symptoms can include: Flu-like symptoms, such as muscle aches and a high temperature (fever) Feeling tired all the time Loss of appetite Stomach ache Feeling and being sick The only way to know for certain if these symptoms are caused by hepatitis C is to get tested. How do you contract Hepatitis C? The hepatitis C virus typically spreads via blood-to-blood transmission. Various methods of infection transmission include: Sharing unsterilised needles – particularly needles used to inject recreational drugs Sharing razors or toothbrushes From a pregnant woman to her unborn baby Through unprotected sex, although this is very rare It's estimated that approximately half of the individuals who inject drugs have been infected with the virus. Wondering how to get tested for Hepatitis C? If you're experiencing persistent symptoms of hepatitis C or believe you may be at risk of infection, even in the absence of symptoms, it's crucial to seek medical advice. A blood test can determine whether you're infected. The NHS recommends a home finger-prick test to check for hepatitis C, as mentioned in their Instagram post. Testing for hepatitis C is also available at GP surgeries, sexual health clinics, genitourinary medicine (GUM) clinics, and drug treatment services. Prompt diagnosis and treatment can help prevent or limit liver damage and ensure the infection isn't passed on to others. Hepatitis C can be managed with medications that inhibit the virus from multiplying within the body, typically requiring several weeks of treatment.
The Independent
5 days ago
- The Independent
Health expert on the risk factors for liver cancer
Liver cancer cases are projected to increase significantly, from 0.87 million in 2022 to 1.52 million by 2050, according to a Lancet Commission on Liver Cancer report. Rising obesity rates are a major contributing factor, with the proportion of liver cancer cases linked to obesity expected to double from 5 per cent to 11 per cent. Around three out of four cancers that start in the liver are hepatocellular carcinoma (HCC), which frequently develops in livers scarred by conditions such as excessive alcohol consumption or Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Early stages of liver cancer often show no symptoms, but advanced signs include jaundice, unexplained weight loss, and fatigue, with diagnosis typically involving ultrasound, CT, and MRI scans. Treatment options are diverse, ranging from curative surgeries like liver resection, transplant, or ablation for early detection, to other methods such as chemoembolisation for more advanced cases.
Daily Record
5 days ago
- Daily Record
UKHSA issues warning over deadly disease 'without symptoms'
The UK Health Security Agency is urging people to undergo a test for a potentially deadly disease - but you may not even know you have it The UK Health Security Agency (UKHSA) is calling on the public to get screened for a potentially fatal illness. The UKHSA works to prevent, prepare for and tackle infectious diseases and environmental threats to safeguard the nation's wellbeing. The agency has issued an alert regarding Hepatitis C, a virus typically transmitted through blood-to-blood contact with someone who is infected. Across Britain, it is predominantly passed on via shared needles amongst drug users. Beyond UK borders, substandard medical practices are generally the culprit. Worldwide, roughly 50 million individuals are living with chronic hepatitis C, while around 1 million fresh cases emerge annually. During 2022, hepatitis C was responsible for approximately 242,000 fatalities, chiefly due to cirrhosis and liver cancer. Thankfully, figures have plummeted considerably across the UK in recent times. From 2015 to 2023, chronic hepatitis C cases amongst England's general population dropped dramatically by 56.7 per cent, reports Surrey Live. Enhanced treatment availability has also resulted in a minimal hepatitis C-related death rate of 0.41 per 100,000 people. Expanded testing programmes are believed to have contributed to this decline, prompting the UKHSA to encourage screening for those meeting specific criteria. The UKHSA stated: "Have you had a blood transfusion before 1996? Blood transfusions before 1992 and blood products before 1986 in the UK were not routinely tested for hepatitis C. "Have you ever shared a needle or other equipment for injecting drugs? Have you ever had medical, dental, or cosmetic treatment at home or abroad in unsterile conditions? Have you ever had condomless sex, or shared a razor or toothbrush with someone who might have hepatitis C? "Have you had a household contact, close family member, or sexual partner with hepatitis C? Were you born in a counter where hepatitis C is more common? This includes countries in Africa, Eastern Europe, the Middle East, the South Caucasus, and Central Asia? "If you've answered yes to any of these questions, there may be a chance you have come into contact with hepatitis C. Speak to your GP about getting tested." Hepatitis C - the facts The NHS explains that hepatitis C stems from the hepatitis C virus. It frequently presents with minimal or no obvious symptoms, or merely flu-like signs, meaning countless individuals remain oblivious to their infection. Certain people will successfully combat the infection and eliminate the virus from their system. However, in other instances, it remains dormant in the body for numerous years. This condition is termed chronic hepatitis C and may lead to cirrhosis, liver failure, and cancer. Chronic hepatitis C responds well to highly effective antiviral treatments, though no preventative vaccine currently exists. Without proper treatment, it can trigger severe symptoms and potentially fatal liver damage. The UKHSA is striving to meet the World Health Organisation's goal of eradicating hepatitis C by 20230. It's estimated that around 92,900 individuals in the UK are living with chronic hepatitis C infection, marking a significant 47 per cent reduction since 2015.
